Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cipla
Express Scripts
US Army
Mallinckrodt
McKinsey
UBS
Healthtrust
Farmers Insurance
Chubb

Generated: January 18, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,858,584

« Back to Dashboard

Summary for Patent: 6,858,584
Title: Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
Abstract:Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.
Inventor(s): Judice; J. Kevin (El Granada, CA), Shaw; Jeng-Pyng (Saratoga, CA), Mu; YongQi (Los Altos, CA), Conner; Michael W. (Half Moon Bay, CA), Pace; John L. (San Anselma, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Application Number:09/846,893
Patent Claims: 1. A pharmaceutical composition comprising: (a) a cyclodextrin; and (b) a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof.

2. The pharmaceutical composition of claim 1 which further comprises water.

3. The pharmaceutical composition of claim 1 which is a powder.

4. The pharmaceutical composition of claim 1 which is a lyophilized powder.

5. A pharmaceutical composition comprising: (a) an aqueous cyclodextrin carrier and (b) a therapeutically effective amount of a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof.

6. The pharmaceutical composition of claim 5, wherein the pharmaceutical composition comprises: (a) a therapeutically effective amount of a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof; (b) 1 to 40 weight percent of a cyclodextrin; and (c) 60 to 99 weight percent of water based on 100 weight percent of the composition.

7. The pharmaceutical composition of claim 5, wherein the cyclodextrin is hydroxypropyl-.beta.-cyclodextrin or sulfobutyl ether .beta.-cyclodextrin.

8. The pharmaceutical composition of claim 7, wherein the cyclodextrin is hydroxypropyl-.beta.-cyclodextrin.

9. The pharmaceutical composition of claim 6, wherein the cyclodextrin comprises about 5 to 35 weight percent of the composition.

10. The pharmaceutical composition of claim 9, wherein the cyclodextrin comprises about 10 to 30 weight percent of the composition.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Teva
Merck
Chubb
Chinese Patent Office
Federal Trade Commission
Covington
Moodys
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot